İ. ÇELİK Et Al. , "Design, synthesis, and molecular docking studies of benzimidazole-1,3,4-triazole hybrids as carbonic anhydrase I and II inhibitors," CHEMICAL BIOLOGY & DRUG DESIGN , vol.103, no.1, 2024
ÇELİK, İ. Et Al. 2024. Design, synthesis, and molecular docking studies of benzimidazole-1,3,4-triazole hybrids as carbonic anhydrase I and II inhibitors. CHEMICAL BIOLOGY & DRUG DESIGN , vol.103, no.1 .
ÇELİK, İ., Cevik, U. A., Kucukoglu, K., NADAROĞLU, H., BOSTANCI, H. E., Isik, A., ... ÖZKAY, Y.(2024). Design, synthesis, and molecular docking studies of benzimidazole-1,3,4-triazole hybrids as carbonic anhydrase I and II inhibitors. CHEMICAL BIOLOGY & DRUG DESIGN , vol.103, no.1.
ÇELİK, İSMAİL Et Al. "Design, synthesis, and molecular docking studies of benzimidazole-1,3,4-triazole hybrids as carbonic anhydrase I and II inhibitors," CHEMICAL BIOLOGY & DRUG DESIGN , vol.103, no.1, 2024
ÇELİK, İSMAİL Et Al. "Design, synthesis, and molecular docking studies of benzimidazole-1,3,4-triazole hybrids as carbonic anhydrase I and II inhibitors." CHEMICAL BIOLOGY & DRUG DESIGN , vol.103, no.1, 2024
ÇELİK, İ. Et Al. (2024) . "Design, synthesis, and molecular docking studies of benzimidazole-1,3,4-triazole hybrids as carbonic anhydrase I and II inhibitors." CHEMICAL BIOLOGY & DRUG DESIGN , vol.103, no.1.
@article{article, author={İSMAİL ÇELİK Et Al. }, title={Design, synthesis, and molecular docking studies of benzimidazole-1,3,4-triazole hybrids as carbonic anhydrase I and II inhibitors}, journal={CHEMICAL BIOLOGY & DRUG DESIGN}, year=2024}